Histogen to Present at the Canaccord Genuity 41st Annual Growth Conference

Rhea-AI Summary

Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company, is set to present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021, at 2:00 p.m. Eastern Time. Richard W. Pascoe, President and CEO, will lead the presentation, which will focus on the company’s innovative restorative therapeutics aimed at enhancing biological function. For those unable to attend live, a replay will be available for 90 days on Histogen's investors page.

News Market Reaction – HSTO

+6.61%

+6.61% Session move

In the trading session that priced this news, HSTO gained 6.61%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the Canaccord Genuity 41^st Annual Growth Conference. The virtual presentation is scheduled for Thursday, August 12, 2021 at 2:00 p.m. Eastern Time.

Presentation Details

Date: Thursday, August 12, 2021
Time: 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time)
Live Webcast Link: https://wsw.com/webcast/canaccord60/his/2247696

For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.histogen.com.

About Histogen Inc.

Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including joint cartilage regeneration, spinal disk repair, hair growth, and dermal rejuvenation. For more information, please visit www.histogen.com.

CONTACT:
Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com

FAQ

When is Histogen's presentation at the Canaccord Genuity 41st Annual Growth Conference?

Histogen's presentation is scheduled for August 12, 2021, at 2:00 p.m. Eastern Time.

Who will present at the Canaccord Genuity conference for Histogen?

Richard W. Pascoe, President and CEO of Histogen, will present at the conference.

How can I watch Histogen's presentation live?

You can watch Histogen's presentation live via the webcast link provided in their press release.

Will there be a replay of Histogen's presentation?

Yes, a replay will be available for 90 days on Histogen's investors page.

What is the focus of Histogen Inc. and its therapies?

Histogen Inc. focuses on developing restorative therapeutics that promote the body’s natural repair processes.